Preferred Label : SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator;
NCIt related terms : SUSAR Reporting to EVCTM Indicator; SREVIND;
NCIt definition : An indication as to whether suspected unexpected serious adverse reactions will be
reported to a EudraVigiliance clinical trial module.;
Alternative definition : CDISC: An indication as to whether suspected unexpected serious adverse reactions
(SUSAR) will be reported to a EudraVigiliance clinical trial module (EVCTM).;
NCI Metathesaurus CUI : CL504671;
Origin ID : C126073;
UMLS CUI : C4288259;
Semantic type(s)
concept_is_in_subset